u/ferran_mensah
Contributes reviews on supplier material. Based in Odense.
member · joined 14 May 2025
Overview — page 2 of 5
comment on non-scale victory — my 20-week log, condensed into one table in c/progresspics · 15 points · 2 months ago
starting point, current point, timeframe, dose history
comment on reading SURMOUNT threads from 2024 and half of it aged badly in c/tirzepatide · 33 points · 3 months ago
Mechanistically the bit that matters is GIP. It explains most of the early profile and a decent chunk of the outcome.
comment on week 16 check-in — 36kg down, sulphur burps manageable, one thing confusing me in c/glp1uk · 2 points · 3 months ago
What is today's date for the pricing?
comment on [Question] Australia — has anyone got a straight answer on dual agonist in c/tirzepatide · 143 points · 4 months ago
Not to be pedantic but SURPASS and SURMOUNT are being used interchangeably and they are not interchangeable in real life.
comment on someone explain 15mg to me like I have not read a paper in years in c/tirzepatide · 46 points · 4 months ago
What was the trial arm you are quoting from? SURMOUNT-1, -2, -3 are all different.
comment on [PSA] tier 3 is not what most of this community thinks it is in c/glp1uk · 63 points · 4 months ago
the tier 3 pathway is the only free route, it is slow
comment on reading CagriSema threads from 2024 and half of it aged badly in c/cagrilintide · 2 points · 5 months ago
the amylin agonist pool is small, community is cagrilintide
comment on Spain: PBS, and what it actually costs here in c/glp1aus · 92 points · 5 months ago
AU and NZ are different systems, say which
comment on milestone is the most under-discussed thing in c/bloodwork in c/progresspics · 12 points · 5 months ago
Has anyone actually got this in writing, or is it forum lore at this point?
comment on New Zealand is the most under-discussed thing in c/glp1science in c/glp1aus · 1 points · 6 months ago
the 2024 compounding rule change closed a major route overnight
comment on PCOS — my 11-week log, condensed into one table in c/glp1women · 33 points · 6 months ago
the cycle tracking data matters, keep it private
comment on [Results] 46 weeks on 1.7mg, full numbers, ask me anything boring in c/cagrilintide · 25 points · 6 months ago
the amylin agonist pool is small, community is amylin
Disagree on that part. 95.1% and 99.2% on the same vial is normal.
comment on [PSA] shortage is not what most of this community thinks it is in c/glp1aus · 33 points · 7 months ago
PBS listings change the cost completely
comment on someone explain non-scale victory to me like I have not read a paper in years in c/progresspics · 87 points · 7 months ago
the milestone milestone is worth posting
comment on why does nobody talk about tier 3 in c/glp1uk · 13 points · 7 months ago
Strongly agree. tier 3 is region-specific.
comment on my ApoB moved and I cannot work out whether Australia is why in c/glp1aus · 3 points · 8 months ago
Cite the TGA notice?
comment on anyone else notice 15mg kicking in around week 24 in c/tirzepatide · 42 points · 8 months ago
the dual agonism hits different and that is why people describe it differently
comment on [Discussion] we are measuring Australia at the wrong time and calling it noise in c/glp1aus · 1 points · 8 months ago
You have restated the marketing copy. What is the actual substance here.
comment on [Question] Ireland — has anyone got a straight answer on 503A in c/compounding · -3 points · 8 months ago
Yeah, 503A and 503B are different regulatory animals.
comment on [Question] New Zealand — what am I missing here in c/glp1aus · 3 points · 9 months ago
Yeah, the 2024 rule change was sudden.